In close collaboration with universities and physicians world - wide, our comprehensive investigational stem
cell treatments employ well - targeted combinations of allogeneic human umbilical cord stem cells, autologous bone marrow stem cells, and autologous adipose stem cells for the diseases listed below.
Not exact matches
The researchers concluded that if vitamin D is to be used in patients with rheumatoid arthritis, clinicians may need to prescribe much higher doses than currently
employed or provide a
treatment that also corrects the vitamin D insensitivity of immune
cells within the joint.
The single -
cell - analysis approach could likely be
employed to develop personalized
treatment for many other types of cancer as well.
iPS
cells have been
employed to generate
cells for the
treatment of various diseases including diabetes, cardiovascular disease, sickle
cell anaemia, Parkinson's disease and haemophilia [19]--[23].
Acute myeloid leukemia (AML) is the leading cause of leukemia mortality in the United States.1 Curative
treatment involves intensive induction chemotherapy, before proceeding to either consolidation chemotherapy or allogeneic stem
cell transplantation based on the patient's risk for relapse.2 This approach has been
employed for > 4 decades and, although most individuals achieve complete remissions with front - line therapy, 3 the majority of patients ultimately relapse with drug - resistant disease, and overall survival rates remain disappointingly poor.4 The limited ability of many patients to tolerate the intense chemotherapy - based
treatments, in particular hematological toxicity, further contributes to the poor outcomes noted in this disease.